| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |